Ethyl pyruvate attenuates ventilation-induced diaphragm dysfunction through high-mobility group box-1 in a murine endotoxaemia model
- PMID: 31339670
- PMCID: PMC6652995
- DOI: 10.1111/jcmm.14478
Ethyl pyruvate attenuates ventilation-induced diaphragm dysfunction through high-mobility group box-1 in a murine endotoxaemia model
Abstract
Mechanical ventilation (MV) can save the lives of patients with sepsis. However, MV in both animal and human studies has resulted in ventilator-induced diaphragm dysfunction (VIDD). Sepsis may promote skeletal muscle atrophy in critically ill patients. Elevated high-mobility group box-1 (HMGB1) levels are associated with patients requiring long-term MV. Ethyl pyruvate (EP) has been demonstrated to lengthen survival in patients with severe sepsis. We hypothesized that the administration of HMGB1 inhibitor EP or anti-HMGB1 antibody could attenuate sepsis-exacerbated VIDD by repressing HMGB1 signalling. Male C57BL/6 mice with or without endotoxaemia were exposed to MV (10 mL/kg) for 8 hours after administrating either 100 mg/kg of EP or 100 mg/kg of anti-HMGB1 antibody. Mice exposed to MV with endotoxaemia experienced augmented VIDD, as indicated by elevated proteolytic, apoptotic and autophagic parameters. Additionally, disarrayed myofibrils and disrupted mitochondrial ultrastructures, as well as increased HMGB1 mRNA and protein expression, and plasminogen activator inhibitor-1 protein, oxidative stress, autophagosomes and myonuclear apoptosis were also observed. However, MV suppressed mitochondrial cytochrome C and diaphragm contractility in mice with endotoxaemia (P < 0.05). These deleterious effects were alleviated by pharmacologic inhibition with EP or anti-HMGB1 antibody (P < 0.05). Our data suggest that EP attenuates endotoxin-enhanced VIDD by inhibiting HMGB1 signalling pathway.
Keywords: endotoxaemia; ethyl pyruvate; high-mobility group box-1; mitochondria; ventilator-induced diaphragm dysfunction.
© 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Conflict of interest statement
The authors confirm that there are no conflicts of interest.
Figures
Similar articles
-
Attenuation of ventilation-induced diaphragm dysfunction through toll-like receptor 4 and nuclear factor-κB in a murine endotoxemia model.Lab Invest. 2018 Sep;98(9):1170-1183. doi: 10.1038/s41374-018-0081-0. Epub 2018 Jun 20. Lab Invest. 2018. PMID: 29925937
-
Reduction in Ventilation-Induced Diaphragmatic Mitochondrial Injury through Hypoxia-Inducible Factor 1α in a Murine Endotoxemia Model.Int J Mol Sci. 2022 Jan 19;23(3):1083. doi: 10.3390/ijms23031083. Int J Mol Sci. 2022. PMID: 35163007 Free PMC article.
-
Ethyl pyruvate reduces ventilation-induced neutrophil infiltration and oxidative stress.Exp Biol Med (Maywood). 2012 Jun;237(6):720-7. doi: 10.1258/ebm.2012.011184. Epub 2012 Jun 19. Exp Biol Med (Maywood). 2012. PMID: 22715434
-
Ventilator-induced diaphragm dysfunction in critical illness.Exp Biol Med (Maywood). 2018 Dec;243(17-18):1329-1337. doi: 10.1177/1535370218811950. Epub 2018 Nov 19. Exp Biol Med (Maywood). 2018. PMID: 30453774 Free PMC article. Review.
-
Ethyl pyruvate: a novel treatment for sepsis.Novartis Found Symp. 2007;280:147-56; discussion 156-64. Novartis Found Symp. 2007. PMID: 17380793 Review.
Cited by
-
High mobility group box-1: a potential therapeutic target for allergic rhinitis.Eur J Med Res. 2023 Oct 12;28(1):430. doi: 10.1186/s40001-023-01412-z. Eur J Med Res. 2023. PMID: 37828579 Free PMC article. Review.
-
Protective role of ethyl pyruvate in spinal cord injury by inhibiting the high mobility group box-1/toll-like receptor4/nuclear factor-kappa B signaling pathway.Front Mol Neurosci. 2022 Sep 16;15:1013033. doi: 10.3389/fnmol.2022.1013033. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36187352 Free PMC article. Review.
-
Low-Molecular-Weight Heparin Reduces Ventilation-Induced Lung Injury through Hypoxia Inducible Factor-1α in a Murine Endotoxemia Model.Int J Mol Sci. 2020 Apr 28;21(9):3097. doi: 10.3390/ijms21093097. Int J Mol Sci. 2020. PMID: 32353952 Free PMC article.
References
-
- Petrof BJ. Diaphragm weakness in the critically ill: basic mechanisms reveal therapeutic opportunities. Chest. 2018;154:1395‐1403. - PubMed
-
- Jung B, Moury PH, Mahul M, et al. Diaphragmatic dysfunction in patients with ICU‐acquired weakness and its impact on extubation failure. Intensive Care Med. 2016;42:853‐861. - PubMed
-
- Jaber S, Petrof BJ, Jung B, et al. Rapidly progressive diaphragmatic weakness and injury during mechanical ventilation in humans. Am J Respir Crit Care Med. 2011;183:364‐371. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
